Filing Flows › Foxo Technologies (FOXO) › Q2 2026 › vs Q1 2026
Foxo Technologies (FOXO) Q2 2026 vs Q1 2026 (quarter over quarter)
Foxo Technologies's revenue fell $453K (-9%) from $5.2M in Q1 2026 to $4.7M in Q2 2026. The biggest changes: Health Cares −$328K (-7%); Life Science Services −$123K (-34%); Labs +$2K (+41%). Operating margin 185.5% against -5.4% (+190.9 pts).
Foxo Technologies, Q2 2026: revenue $4.7M (-10% year over year), operating margin 185.5%, net earnings $8.1M, operating cash flow $299K. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 185.5% | -5.4% | +190.9 pts |
| Net margin | 172.6% | -28.2% | +200.7 pts |
| Free cash flow margin | 6.2% | -11.3% | +17.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Health Cares | $4.5M | $4.8M | −$328K | -7% |
| Life Science Services | $238K | $361K | −$123K | -34% |
| Labs | $6K | $4K | $2K | +41% |
| Revenue | $4.7M | $5.2M | −$453K | -9% |
| Operating profit | $8.7M | −$277K | $9.0M | — |
| Pre-tax earnings | $8.1M | −$1.5M | $9.6M | — |
| Other expense, net | $612K | $1.2M | −$567K | -48% |
| Net earnings | $8.1M | −$1.5M | $9.6M | — |
| Depreciation & amortization | $176K | $171K | $5K | +3% |
| Working capital & other | $8.0M | −$706K | $8.7M | — |
| Operating cash flow | $299K | −$578K | $877K | — |
| Free cash flow (OCF − capex) | $293K | −$582K | $875K | — |
| Capital expenditures | $5K | $4K | $1K | +35% |
Questions
How much did Foxo Technologies's revenue grow quarter over quarter in Q2 2026?
Foxo Technologies's revenue fell $453K (-9%) from $5.2M in Q1 2026 to $4.7M in Q2 2026.
What drove Foxo Technologies's revenue change in Q2 2026?
Health Cares −$328K (-7%); Life Science Services −$123K (-34%); Labs +$2K (+41%).